Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Fronza

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Human Gene Therapy|June 4, 2025
Recombinant Adeno-Associated Virus Integration Profiles in Nonhuman Primates and Gene Therapy Participants after Treatment with Valoctocogene RoxaparvovecChris B Russell, Christian Vettermann, Suresh Agarwal, et al.
Gene Therapy|May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survivalSaqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Gene Therapy|July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Science Translational Medicine|December 15, 2015
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memoryGiacomo Oliveira, Eliana Ruggiero, Maria Teresa Lupo Stanghellini, et al.
Current Gene Therapy|November 28, 2014
Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell diseaseOlivier Negre, Cynthia Bartholomae, Yves Beuzard, et al.
Nature Communications|February 19, 2021
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patientsMaria Xydia, Raheleh Rahbari, Eliana Ruggiero, et al.
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Science Translational Medicine|March 14, 2014
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicityChristian Jörg Braun, Kaan Boztug, Anna Paruzynski, et al.
Human Gene Therapy. Clinical Development|July 13, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous diseaseStefan Stein, Simone Scholz, Joachim Schwäble, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Human Gene Therapy|June 4, 2025
Recombinant Adeno-Associated Virus Integration Profiles in Nonhuman Primates and Gene Therapy Participants after Treatment with Valoctocogene RoxaparvovecChris B Russell, Christian Vettermann, Suresh Agarwal, et al.
Gene Therapy|May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survivalSaqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Gene Therapy|July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Science Translational Medicine|December 15, 2015
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memoryGiacomo Oliveira, Eliana Ruggiero, Maria Teresa Lupo Stanghellini, et al.
Current Gene Therapy|November 28, 2014
Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell diseaseOlivier Negre, Cynthia Bartholomae, Yves Beuzard, et al.
Nature Communications|February 19, 2021
Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patientsMaria Xydia, Raheleh Rahbari, Eliana Ruggiero, et al.
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Science Translational Medicine|March 14, 2014
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicityChristian Jörg Braun, Kaan Boztug, Anna Paruzynski, et al.
Human Gene Therapy. Clinical Development|July 13, 2013
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous diseaseStefan Stein, Simone Scholz, Joachim Schwäble, et al.
Pageof 4